DBV Technologies (DBVT) Receivables - Other (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Receivables - Other of $2.6 million for Q2 2026, down 9.88% year-on-year from $2.9 million in Q2 2025, and up 160.0% on a QoQ basis from $1.0 million in Q1 2026.
DBV Technologies (DBVT) Receivables - Other (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Receivables - Other for 12 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.
- Quarterly Receivables - Other fell 9.88% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.6 million (down 9.88% YoY) and the FY2025 annual result came in at $1.6 million, down 18.33% from the prior year.
- Receivables - Other climbed to $2.6 million in Q2 2026 per DBVT's latest filing, from $1.0 million in the prior quarter.
- Over the last five years, Receivables - Other for DBVT reached as high as $4.8 million in Q3 2024 and fell as low as $518000.0 in Q1 2024.
- A 5-year average of $1.9 million and a median of $1.5 million in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2023 — Receivables - Other soared 241.49% — and 2024, when it tumbled 81.43%.
- Year by year, Receivables - Other stood at $1.5 million in 2022, then retreated by 10.04% to $1.4 million in 2023, then surged by 44.79% to $2.0 million in 2024, then slipped by 18.33% to $1.6 million in 2025, then jumped by 62.5% to $2.6 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $2.6 million, $1.0 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.60 Mn |
| Jun 30, 2026 | 2.60 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 4.84 Mn |
| Sep 30, 2024 | 4.84 Mn |
| Jun 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 3.42 Mn |
| Mar 31, 2024 | 518,000.00 |
| Mar 31, 2024 | 518,000.00 |